Storia in 2 fonti

What's Going On With Neurocrine Biosciences Stock On Wednesday? - Neurocrine Biosciences (NASDAQ:NBIX)

Reports of serious adverse events and deaths linked to Neurocrine's VYKAT XR for Prader-Willi syndrome prompt caution.

Raccontata da

benzinga.com

endpoints.news

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo1 g fa

What's Going On With Neurocrine Biosciences Stock On Wednesday? - Neurocrine Biosciences (NASDAQ:NBIX)

Reports of serious adverse events and deaths linked to Neurocrine's VYKAT XR for Prader-Willi syndrome prompt caution.

originale

endpoints.news1 g fa

Four questions on new safety warnings for Neurocrine’s Vykat XR

The treatment has been linked to seven deaths, largely due to heart or respiratory problems. It has also been associated with over 100 serious adverse events in Prader-Willi patients, raising safety and sales concerns.

Leggi questa versione → originale

Timeline cronologica

mercoledì 12 agosto 2026·benzinga.com
What's Going On With Neurocrine Biosciences Stock On Wednesday? - Neurocrine Biosciences (NASDAQ:NBIX)
Reports of serious adverse events and deaths linked to Neurocrine's VYKAT XR for Prader-Willi syndrome prompt caution.
mercoledì 12 agosto 2026·endpoints.news
Four questions on new safety warnings for Neurocrine’s Vykat XR
The treatment has been linked to seven deaths, largely due to heart or respiratory problems. It has also been associated with over 100 serious adverse events in Prader-Willi…